Nanoengineered Sprayable Therapy for Treating Myocardial Infarction
Frontiers The grand challenge of discovering new cardiovascular drugs
Frontiers Risk stratification in transthyretin-related cardiac amyloidosis
Frontiers Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets
Left Ventricular Remodeling After Myocardial Infarction
IJERPH, Free Full-Text
Assessment of Left Ventricular Function by Echocardiography: The Case for Routinely Adding Global Longitudinal Strain to Ejection Fraction
Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
Smart wearable devices in cardiovascular care: where we are and how to move forward
Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic
Frontiers Potential Role of Autonomic Dysfunction in Covid-19 Morbidity and Mortality
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Persistent cardiac injury – An important component of long COVID-19 syndrome - eBioMedicine
Frontiers Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study
COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies